Summary
The potent benzodiazepine receptor ligands β-carboline-3-carboxylic acid ethyl ester (β-CCM) and the corresponding methylester (β-CCM) administered i.v. depressed segmental dorsal root potentials in spinal cats, reversed the prolongation of dorsal root potentials by phenobarbitone, and abolished the depression of a motor performance task induced by phenobarbitone in mice; β-CCE enhanced the low-frequency facilitation of pyramidal population spikes in the hippocampus of anaesthetized rats. These effects of β-carbolines reflect a depression of GABAergic synaptic transmission and, thus, are diametrically opposed to the enhancing action of benzodiazepine tranquilizers. The specific benzodiazepine antagonist, Ro 15-1788, while not affecting dorsal root potentials, hippocampal population spikes or phenobarbitone-induced motor performance depression, abolished the effects of β-CCE on the three parameters and similar effects of β-CCM on the spinal cord and motor performance.
A three-state model of the benzodiazepine receptor is proposed in which benzodiazepine tranquilizers act as agonists enhancing the function of the benzodiazepine receptor as a coupling unit between GABA receptor and chloride channel, β-carbolines act as “inverse agonists” reducing this coupling function, and Ro 15-1788 represents a competitive antagonist blocking both the enhancing effect of agonists and the depressant effect of “inverse agonists” on GABAergic synaptic transmission.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Ahlquist J, Brown MW, Rose D (1982) The effects of amnesia-producing drugs on hippocampal potentiation in the rat. Br J Pharmacol 75:48P
Ben-Ari Y, Krnjevic K, Reinhardt W (1979) Hippocampal seizures and failure of inhibition. Can J Physiol Pharmacol 57:1462–1466
Bernhard P, Bergen K, Sobiski R, Robson RD (1981) CGS 8216 (2-phenylpyrazolo[4,3-c]quinolin-3(5H)-one), an orally effective benzodiazepine antagonist. Pharmacologist 23:150
Besson J-M, Rivot J-P, Aleonard P (1971) Action of picrotoxin on presynaptic inhibition of various origins in the cat's spinal cord. Brain Res 26:212–216
Bonetti EP, Pieri L, Cumin R, Schaffner R, Pieri M, Gamzu ER, Müller RKM, Haefely W (1982) Benzodiazepine antagonist Ro 15-1788: Neurological and behavioral effects. Psychopharmacology 78: 8–18
Braestrup C, Nielsen M, Olsen CE (1980) Urinary and brain β-carboline-3-carboxylates as potent inhibitors of brain benzodiazepine receptors. Proc Natl Acad Sci USA 77:2288–2292
Braestrup C, Schmiechen R, Neef G, Nielsen M, Petersen EN (1982) Interaction of convulsive ligands with benzodiazepine receptors. Science 216:1241–1243
Cepeda C, Tanaka T, Besselièvre R, Potier P, Naquet R, Rossier J (1981) Proconvulsant effects in baboons of β-carboline, a putative endogenous ligand for benzodiazepine receptors. Neurosci Lett 24:53–57
Choi DW, Farb DH, Fischbach GD (1981) Chlordiazepoxide selectively potentiates GABA conductance of spinal cord and sensory neurons in cell culture. J Neurophysiol 45:621–631
Costa E, Guidotti A (1979) Molecular mechanisms in the receptor action of benzodiazepines. Ann Rev Pharmacol Toxicol 19:531–545
Courvoisier S (1956) Pharmacodynamic basis for the use of chlorpromazine in psychiatry. J Clin Exp Psychopathol 17:25–37
Cowen PJ, Green AR, Nutt DJ, Martin IL (1981) Ethyl-β-carboline carboxylate lowers seizure threshold and antagonizes flurazepaminduced sedation in rats. Nature 290:54–55
Gee KW, Yamamura H (1982) A novel pyrazoloquinoline that interacts with brain benzodiazepine receptors: characterization of some in vitro and in vivo properties of CGS 9896. Life Sci 30:2245–2252
Haefely W, Polc P, Schaffner R, Keller HH, Pieri L, Möhler H (1979) Facilitation of GABAergic transmission by drugs. In: Krogsgaard-Larsen P, Scheel-Krüger J, Kofod H (eds) GABA-Neurotransmitters. Munksgaard, Copenhagen, pp 357–375
Haefely W, Pieri L, Polc P, Schaffner R (1981a) General pharmacology and neuropharmacology of benzodiazepine derivatives. In: Hoffmeister F, Stille G (eds) Handbook of experimental pharmacology; Psychotropic agents, vol 55, Part 2. Springer, Berlin Heidelberg New York, pp 13–262
Haefely W, Schaffner R, Pole P, Pieri L (1981b) General pharmacology and neuropharmacology of propanediol carbamates. In: Hoffmeister F, Stille G (eds) Handbook of experimental pharmacology; Psychotropic agents, vol 55, Part 2. Springer, Berlin Heidelberg New York, pp 265–283
Hunkeler W, Möhler H, Pieri L, Polc P, Bonetti EP, Cumin R, Schaffner R, Haefely W (1981) Selective antagonists of benzodiazepines. Nature 290:514–516
Jones BJ, Oakley NR (1981) The convulsant properties of methyl-β-carboline-3-carboxylate in the mouse. Br J Pharmacol 74:884P-885P
Macdonald RL, Barker JL (1979) Enhancement of GABA-mediated postsynaptic inhibition in cultured mammalian spinal cord neurons: a common mode of anticonvulsant action. Brain Res 167:323–336
McMillan JA, Mokha SS (1982) Effects of bicuculline on dorsal root potentials in the cat. J Physiol (London) 322:34P
Möhler H, Richards JG (1981) Agonist and antagonist benzodiazepine receptor interaction in vitro. Nature 294:763–765
Möhler H, Burkard WP, Keller HH, Richards JG, Haefely W (1981) Benzodiazepine antagonist Ro 15-1788: Binding characteristics and interaction with drug-induced changes in dopamine turnover and cerebellar cGMP levels. J Neurochem 37:714–722
Nicoll RA (1978) Selective actions of barbiturates on synaptic transmission. In: Lipton MA, DiMascio A, Killam KF (eds) Psychopharmacology: A generation of progress. Raven Press, New York, pp 1337–1348
Nicoll RA, Alger BE (1979) Presynaptic inhibition: transmitter and ionic mechanisms. Int Rev Neurobiol 21:217–258
Nutt DJ, Cowen PJ, Little HJ (1982) Unusual interactions of benzodiazepine receptor antagonists. Nature 295:436–438
Oakley NR, Jones BJ (1980) The proconvulsant and diazepam-reversing effects of ethyl-β-carboline-3-carboxylate. Eur J Pharmacol 68:381–382
O'Brien RA, Schlosser W, Spirt NM, Franco S, Horst WD, Polc P, Bonetti EP (1981) Antagonism of benzodiazepine receptors by beta carbolines. Life Sci 29:75–82
Olsen RW (1981) GABA-benzodiazepine-barbiturate receptor interactions. J Neurochem 37:1–13
Polc P, Laurent J-P, Scherschlicht R, Haefely W (1981a) Electrophysiological studies on the specific benzodiazepine antagonist Ro 15-1788. Naunyn-Schmiedeberg's Arch Pharmacol 316:317–325
Polc P, Ropert N, Wright DM (1981b) Ethyl β-carboline-3-carboxylate antagonizes the action of GABA and benzodiazepines in the hippocampus. Brain Res 217:216–220
Skerritt JH, Willow M, Johnston GAR (1982) Diazepam enhancement of low affinity GABA binding to rat brain membranes. Neurosci Lett 29:63–66
Study RE, Barker JL (1981) Diazepam and (−)-pentobarbital: Fluctuation analysis reveals different mechanisms for potentiation of γ-amino-butyric acid responses in cultured central neurons. Proc Natl Acad Sci USA 78:7180–7184
Supavilai P, Mannonen A, Karobath M (1982) Modulation of GABA binding sites by CNS depressants and CNS convulsants. Neurochem Int 4:259–268
Tenen SS, Hirsch JD (1980) β-Carboline-3-carboxylic acid ethyl ester antagonizes diazepam activity. Nature 28:609–610
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Polc, P., Bonetti, E.P., Schaffner, R. et al. A three-state model of the benzodiazepine receptor explains the interactions between the benzodiazepine antagonist Ro 15-1788, benzodiazepine tranquilizers, β-carbolines, and phenobarbitone. Naunyn-Schmiedeberg's Arch. Pharmacol. 321, 260–264 (1982). https://doi.org/10.1007/BF00498510
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00498510